Effect of Vitamin E on Ethanol-induced Increase in Some Cardiovascular Parameters and Blood Uric Acid Levels in Man
I. Onyesom ,
U.E. Uzuegbu ,
E.K. Nwangwa ,
Alcohol metabolism has been reported to generate Reactive Oxygen Species (ROS) which initiate series of oxidative reactions that culminate in hyperuricemia and accompanying cardiovascular dysfunction. Present study investigates the effect of a free radical scavenger-vitamin E, on alcohol-induced increase in serum uric acid, triacylglycerol and blood pressure. One hundred consenting undergraduates (60 males and 40 females) in apparent good health and who were matched in age, weight and body build were selected and tested on four different occasions separated by 14 days. On the first day of testing, the subjects were randomly separated into Groups A (0.75 mL fruit juice/kg + 100 mg tapioka dried cassava product: n = 25), Group B (0.75 ml ethanol/kg+ 100 mg tapioka: n = 25), Group C (0.75 mL ethanol/kg + 100 mg vitamin E:n = 25) and Group D (0.75 mL fruit juice/kg + 100 mg vitamin E: n = 25) and were treated as indicated. The ethanol administered was diluted to 30% with fruit juice. Each participant was rotated every forthnight until he/she completes the four rounds of testing. The data obtained show that the co-administration of ethanol and vitamin E significantly reduced (p<0.05) the level of serum uric acid and the proportion of subjects in the prehypertension and stage 1 hypertension classes induced by ethanol consumption alone. Apart from confirming the recent proposal that links ROS to hyperuricemia and secondary cardiovascular disorders, this study suggests that boosting the level of antioxidant vitamins in the body could alleviate the ethanol-induced hyperuricemia and perhaps, associated disease conditions.
Most urinary uric acid appears to be derived from tubular secretion (Wang et al., 2001), since about 98-100% of the amount filtered is reabsorbed. The presence of organic acids like lactic acid and ketoacids have been reported to impair the proximal secretion of uric acid (Fahlen and Agraharkar, 2003), consequently, elevating the level of plasma uric acid. The chief risk of uric acid elevation include gout and kidney stones (Fields, 2003). Increase in blood uric acid has been associated with hypertension and renal disease (Johnson et al., 2003), however, there is no proven, causative role of hyperuricemia for these group of diseases.
Alcohol consumption has been demonstrated to increase plasma uric acid level by several workers (Faller and Fox, 1982; Beghi et al., 1995; Onyesom, 2003). Increase in the NADH:NAD+ ratio produced during the oxidation of ethanol, elevates plasma lactate (Tygstrup et al., 1965) which in turn decreases the sensitivity of the tubular epithelial cells to uric acid secretion and consequently, the ability of the kidneys to excrete uric acid is reduced.
In addition, the ethanol-induced increase in NADH:NAD+ ratio has been observed to stimulate mitochondrial respiratory chain (Bailey et al., 1999). Such stimulation causes the generation of reactive oxygen species (Bailey and Cunningham, 1998) which has been connected to hyperuricemia (Houston et al., 1998). In view of this, we investigated the effect of vitamin E, (a lipophilic antioxidant capable of reducing the level of free radicals and their mediated actions in the body) on the changes in serum uric acid, triacylglycerol and blood pressure measures induced by ethanol in humans.
MATERIALS AND METHODS
One hundred consenting undergraduates (60 males and 40 females) in apparent
good health, between the ages of 20 and 30 years were screened for drug use
and selected for the study. Their mean±SD body weight is 60.2±10.5
kg (range: 50-70 kg). The volunteers were light drinkers of alcohol (between
1-2 drinks/day) and they neither smoke cigarette nor snuff tobacco or other
addictive agents. They were not on any medication and they remained so throughout
the period of the investigation. The participants were asked not to drink alcohol
or take medications the night prior to testing, but were advised to eat a light
breakfast at about 7 am and then not to eat, drink or smoke from that time until
reporting to the laboratory at 8:30 am, because food in the stomach might influence
alcohol effects in the body.
Experimental Groups and Testing Exercise
On arrival to the laboratory as scheduled, the participants willingly endorsed
the Human Rights and Ethics form provided as a means of seeking their consent.
They were then weighed and randomly separated into four groups: group A (control
group), Group B (ethanol group), group C (ethanol + vitamin E group) and Group
D (Vitamin E group). Subjects participation was approved by our Facultys
On the first occasion, Group A subjects were given 0.75 mL fruit juice/kg body weight and 100 mg tapioka- a placebo. Tapioka is a dried cassava product. It contains starch and fibre mainly and is commonly eaten between meals. Group B participants orally received 0.75 mL (80 proof USP) ethanol/kg body weight after diluting to 30% with fruit juice and 100 mg tapioka. Proof is the common unit used to express the amount of ethanol in spirits and is double the concentration of ethanol in per cent (%). The volunteers in group C drank the same dose of ethanol 0.75 mL kg-1 and 100 mg vitamin E (made by PROCAPS Barranquilla, Colombia: NAFDAC Reg No. 04-3796) and Group D members took fruit juice (0.75 mL kg-1) and 100 mg vitamin E.
Each participant was rotated every forthnight until he/she went through the four rounds of testing. The rotation was important in order to limit the effect of intra-individual factor(s) that may likely influence the results of a particular group. The results of the four rounds of tests for each group were pooled and the mean±SD was derived.
The data of each group obtained during the four rounds of testing were pooled and mean±SD was then determined. The dosing regimen was based on previous study on blood alcohol and plasma urate (Onyesom, 2003).
Collection of Blood Sample
At different specified post administration time intervals (0, 3, 6 and 9
h), intravenous whole blood sample was collected into plain sterile tube, then
centrifuged after allowing to clot, at 1, 200 x g for 5 min at room temperature
in order to separate the serum which was decanted into bijou bottle. Sera samples
were analyzed fresh within the hour of collection. The specified time intervals
were based on earlier report (Onyesom and Anosike, 2004).
Serum Uric Acid and Triacylglycerol Assays
The serum uric acid level was measured on a spectrophotometer (Spectronic
21: Milton Roy Co., USA) by the uricase method (Caraway, 1963) using a Randox
kit (ref. Randox UA 230, Randox Laboratories, Ardmore, United Kingdom). Serum
triacylglycerol was determined by a spectrophotometer (Spectronic 21: Milton
Roy Co., USA) using the end-point colorimetric method (Searcy, 1961) and reagent
kit supplied by Teco Diagnostics, USA.
Measurements of Blood Pressure
This was measured shortly before blood sample collection in a well-seated
position after about 10 min of rest using Digital Aneroid Sphygmomanometer (ACCOSSON
MERCURY, CE 0120) as previously described by Moreira et al. (1998).
The study was conducted in 2006 between August and September in the Alcohol Research Laboratory, Department of Medical Biochemistry, Delta State University, Abraka, Nigeria.
Classification of Blood Pressure Measurements and Serum Triacylglycerol
Blood pressure was classified according to current guidelines (Chobanian
et al., 2003) and triacylglycerol levels were classified according to
the National Cholesterol Education Program guidelines (NCEP, 2001).
Analysis of variance (ANOVA) was used to compare mean values followed by
Dunetts test for multiple comparison to determine statistical significance
between the groups. (Winer et al., 1991). EPI computer software package
was used and the level of statistical significant difference was established
at the 5% probability level.
Figure 1 and 2, show that overall, the
level of serum uric acid is higher in males compared with females and the ingestion
of 0.75 mL ethanol/kg by male subjects significantly increased (p<0.05) their
serum uric acid levels after about 3 and 6 hours, when compared with basal (0h)
and corresponding control values. But the 9th h post administration value was
not significantly different from both basal and corresponding control value
||Changes in serum uric acid induced by ethanol and ethanol
+ vitamin E co-administration in male subjects
||Changes in serum uric acid induced by ethanol and ethanol
+ vitamin E co-administration in female subjects
|| Classification of blood pressure measures and serum triacylglycerol
values based on experimentally derived data
|Values are expressed as percentage of n (100) subjects Group
A: 0.75 mL fruit juice/kg + 100 mg tapioka, Group B: 0.75 mL ethanol/kg
+ 100 mg tapioka, Group C: 0.75 mL ethanol/kg + 100 mg vitamin E, Group
D: 0.75 mL fruit juice/kg +100 mg vitamin E, aNCEP (2001)
Vitamin E intake generally reduced (p>0.05) the level of serum uric acid in both genders and ethanol + vitamin E administration was observed to attenuate the serum uric acid level induced by ethanol in both male and female participants.
Table 1 shows that ethanol (0.75 mL kg-1) increased the risk of high blood pressure. The proportion of male and female volunteers in the prehypertension and stage 1 hypertension classes were increased by alcohol consumption and this was significant (p<0.05) after about 6 h of the alcohol intake. Similar trend was observed for serum TAG, though the highest increase in proportion occurred at about the 9th h of alcohol post consumption.
Vitamin E, whether taken alone or co-administered with alcohol was seen to ameliorate the increased proportion in blood pressure and serum TAG induced by alcohol administration alone (Table 1). Intake of Vitamin E supplements may improve the cardiovascular disorders and hyperuricemic condition elicited by alcohol abuse.
Present results (Fig. 1, 2 and Table
1) indicate that vitamin E, an antioxidant having the ability to quench
free radical (oxidation) reactions, appears to reduce the increase in serum
uric acid induced by ethanol. This hyperuricemic-ameliorating potential of vitamin
E seems to suggest that the Reactive Oxygen Species (ROS) generated during the
oxidation of ethanol could contribute to the hyperuricemic condition already
established among alcoholics (Bartimaeus and Eno-Eno, 2002).
The oxidation of ethanol to ethanal and ethanal to ethanoate, alters the NADH/NAD+ redox state and in order to maintain this redox condition, the electron flow along the respiratory chain is increased and this generates ROS. Besides eliciting cell injury (Bailey et al., 1999), ROS has been implicated as a risk factor of ethanol-induced hyperuricemia (Houston et al., 1998). ROS could oxidize endothelial nitrogen (II) oxide, NO to NO3¯ and the latter possibly activates xanthine oxidase via sulfhydryl oxidation (Houston et al., 1998). Xanthine oxidase in turn catalyzes the conversion of hypoxanthine to xanthine and then to uric acid sequentially.
The resulting hyperuricemic condition has been reported to exhibit an increase
in juxtaglomerular rennin and a decrease in macula densa neuronal Nitic Oxide
(NO) synthase enzyme activity (Mazzali et al., 2001). Synergistically,
the hyperuricemia-induced inhibition of NO synthase and ROS-initiated oxidation
of endothelial NO to NO3¯ could significantly deplet the levels
of NO, a potent regulator of vasoreactivity (Koppenol, 1998). This may be another
mechanism by which alcohol consumption affects blood pressure (Table
1). However, present study demonstrates that Vitamin E supplements could
improve the hyperuricemic condition (Fig. 1 and 2)
and disturbances in serum TAG and blood pressure (Table 1)
elicited by alcohol consumption.
From this study, it appears reasonable to conclude that ethanol-induced generation of ROS may elicit some biochemical processes that could lead to hyperuricemia and possibly, hypertension. Thus, increasing the level of vitamin E to augment natural antioxidants in the body, possibly via enriched diet (or supplements) may be a good nutritional support (or intervention therapy) if the purpose is to reduce the effects of ROS on serum uric acid and cardiovascular dysfunction elicited by ethanol metabolism.
1: Bailey, S.M. and C.C. Cunningham, 1998. Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh isolated rat hepatocytes. Hepatology, 28: 1318-1326.
2: Bailey, S.M., E.C. Pietsch and C.C. Cunningham, 1999. Ethanol stimulates the production of reactive oxygen species at mitochondria complex I and III. Free Radic. Biol. Med., 27: 891-900.
3: Bartimaeus, E.S. and M. Eno-Eno, 2002. The effect of alcohol on uric acid level in consumers. J. Applied Sci. Environ., 6: 5-7.
Direct Link |
4: Beghi, E., G. Boglium and P. Cossop, 1995. Stroke and alcohol intake in hospital population: A case-control study. Stroke, 26: 1691-1696.
5: Caraway, W.T., 1963. Quantitative determination of uric acid. Clin. Chem., 4: 239-243.
6: Chobanian, A.V., G.L. Bakris, H.R. Black, W.C. Cushman and L.A. Green et al., 2003. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: The JNC 7 report. J. Am. Med. Assoc., 289: 2560-2571.
CrossRef | PubMed | Direct Link |
7: Fahlen, M. and M. Agraharkar, 2003. Nephropathy and uric acid. Med. Com. Inc.
8: Faller, J. and I.H. Fox, 1982. Evidence for increased urate production by activation of adenine nucleotide turnover. N. Eng. J. Med., 307: 1598-1602.
9: Fields, T.R., 2003. Uric acid and cardiovascular disease-chicken or egg? New animal data suggest possible pathogenic role of urate. Hospital for Special Surgery, New York.
10: Houston, M., P. Chumley, R. Radi, H. Rubbo and B.A. Freeman, 1998. Xanthine oxidase reaction with nitric oxide and peroxynitrite. Arch. Biochem. Biophys., 355: 1-8.
11: Johnson, R.J., D.H. Kang, D. Feig, S. Kivlighn and J. Kenellis et al., 2003. Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension, 41: 1183-1190.
Direct Link |
12: Koppenol, W.H., 1998. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic. Biol. Med., 25: 385-391.
PubMed | Direct Link |
13: Mazzali, M., J. Hughes, Y. Kim, A. Jefferson and D. Kang et al., 2001. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension, 38: 1101-1106.
Direct Link |
14: Moreira, L.B., F.D. Fuchs, R.S. Moraes, M. Bredemeier and B.B. Duncan, 1998. Alcohol intake and blood pressure: The importance of time elapsed since last drink. J. Hypertens., 16: 175-180.
15: Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J. Am. Med. Assoc., 285: 2486-2497.
CrossRef | PubMed | Direct Link |
16: Onyesom, I., 2003. Changes in blood pressure and plasma urate induced by the metabolism of alcohol in humans. Global J. Med. Sci., 2: 157-160.
17: Onyesom, I. and E.O. Anosike, 2004. Oral fructose-induced disposition of blood ethanol and associated changes in plasma urate. Afr. J. Drug. Alcohol Stud., 3: 21-30.
18: Searcy, R.L., 1961. Diagnostic Biochemistry. McGraw Hill, New York.
19: Tygstrup, N., K. Winkler and E. Lundquist, 1965. The mechanism of the fructose effect on the ethanol metabolism of the human liver. J. Clin. Invest., 44: 817-830.
20: Wang, J., J.A. Staessen, R.H. Fagard, W.H. Birkenhager, L. Gong and L. Liu, 2001. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension, 37: 1069-1071.
21: Winter, B.K., D.R. Brown and M. Michels, 1991. Design and Analysis of Single-Factor Experiment: Completely Randomized Design Statistical Principles in Experimental Design. McGraw Hill Inc., New York, pp: 374-418.